Israel's Foreign Minister Eli Cohen emphasizes growing strategic partnership with India, highlighting shared terrorism threats and expanding cooperation in defense, technology, and agriculture during crucial diplomatic meetings.
Indian and Israeli officials held high-level talks to boost cooperation in agriculture, trade, and technology during Foreign Minister Eli Cohen's strategic visit to New Delhi, marking a new chapter in bilateral relations.
Eli Lilly is developing Orforglipron oral pills for weight loss and type 2 diabetes that could replace injections, making treatment more accessible and convenient for millions.
Pharmaceutical giant Eli Lilly raises full-year profit forecast as demand skyrockets for revolutionary weight-loss treatment Zepbound, sending shares climbing 7%.
Canadian official Doug Ford confronts US Ambassador David Cohen over explosive comments about Ontario's business policies, sparking diplomatic tension between allies.
Israeli Foreign Minister Eli Cohen embarks on crucial India visit to bolster bilateral relations, discuss defense cooperation, and address regional security concerns amid growing Middle East tensions.
Pharmaceutical giant Eli Lilly partners with NVIDIA to deploy cutting-edge AI supercomputers that will accelerate drug development and transform pharmaceutical research.
Cipla's stock faces unexpected pressure despite securing rights to manufacture and distribute Eli Lilly's revolutionary weight loss drug Mounjaro in India. Discover why investors remain cautious.
Indian pharmaceutical giant Cipla announces landmark deal with Eli Lilly to manufacture and distribute popular weight loss medications Mounjaro and Zepbound in India under different brand names.
Pharma giant Eli Lilly collaborates with Indian partner Cipla to introduce groundbreaking obesity and diabetes treatments Mounjaro and Yurpeak in the Indian market, expanding access to innovative weight management solutions.